Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine vs Standard Bupivacaine in Colorectal Surgery
NCT03702621Phase 3Completed
- Sponsor
- Indiana University
- Start
- Aug 2018
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Indiana University. Primary endpoints: Visual Analog Scale Score at Rest at 72 hours and Visual Analog Scale Score With Movement at 72 hours. Started Aug 2018; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03702621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702621.